{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:05:16Z","timestamp":1761717916587},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ctrv.2003.09.004","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T14:09:05Z","timestamp":1069682945000},"page":"291-301","source":"Crossref","is-referenced-by-count":51,"title":["The effects of tamoxifen on the female genital tract"],"prefix":"10.1016","volume":"30","author":[{"given":"El\u017cbieta","family":"Senkus-Konefka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Konefka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Jassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2003.09.004_BIB1","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1200\/JCO.1999.17.7.2050","article-title":"Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening","volume":"17","author":"Love","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB2","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 1451\u201367","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB4","first-page":"237","article-title":"Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens","volume":"69","author":"Killackey","year":"1985","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14","volume":"86","author":"Fisher","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB6","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/jnci\/85.22.1850","article-title":"Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer","volume":"85","author":"Fornander","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/02841869209088912","article-title":"Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer","volume":"31","author":"Andersson","year":"1992","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB8","unstructured":"IARC. Some pharmaceutical drugs. Lyon, France; IARC Monogr Eval Carcinog Risks Hum 1996; 66: 253\u201365"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0140-6736(00)02670-2","article-title":"One step forward or one step back with tamoxifen?","volume":"356","author":"Gelmon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1023\/A:1018404110180","article-title":"Risk for endometrial cancer following breast cancer: a prospective study in Sweden","volume":"8","author":"Adami","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)71564-6","article-title":"Tamoxifen and risk of endometrial cancer","volume":"357","author":"van Leeuwen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0015-0282(16)58318-6","article-title":"The effects of tamoxifen treatment on the endometrium","volume":"65","author":"Daniel","year":"1996","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X","article-title":"Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC)","volume":"76","author":"Mignotte","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial","volume":"360","author":"Cuzick","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/ejso.1999.0682","article-title":"Tamoxifen and malignant epithelial\u2013nonepithelial tumours of the endometrium: report of six cases and review of the literature","volume":"25","author":"Treilleux","year":"1999","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004040050276","article-title":"The endometrium in breast cancer patients on tamoxifen","volume":"263","author":"Dallenbach-Hellweg","year":"2000","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB19","doi-asserted-by":"crossref","unstructured":"ACOG committee opinion. Tamoxifen and endometrial cancer. Number 169, February 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996; 53: 197\u20139","DOI":"10.1016\/S0020-7292(96)90115-0"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1200\/JCO.1996.14.2.434","article-title":"Effect of tamoxifen on endometrial proliferation","volume":"14","author":"Decensi","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.5859","article-title":"Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer","volume":"78","author":"Deligdisch","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB22","first-page":"134","article-title":"Gynaecological cytology and pelvic ultrasonography in patients with breast cancer taking tamoxifen compared with controls","volume":"20","author":"Rayter","year":"1994","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB23","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1698::AID-CNCR16>3.0.CO;2-#","article-title":"The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma","volume":"82","author":"Katase","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients","volume":"11","author":"Magriples","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"28","key":"10.1016\/j.ctrv.2003.09.004_BIB25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","article-title":"Tamoxifen therapy for breast cancer and endometrial cancer risk","volume":"91","author":"Bernstein","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB27","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2058::AID-CNCR14>3.0.CO;2-U","article-title":"Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use","volume":"77","author":"Cuenca","year":"1996","journal-title":"Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.ctrv.2003.09.004_BIB28","doi-asserted-by":"crossref","first-page":"S-49","DOI":"10.1016\/S0959-8049(98)00112-9","article-title":"Tamoxifen and endometrial cancer: most cancers are early stage and highly curable","volume":"34","author":"Barakat","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/gyno.1994.1271","article-title":"Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features","volume":"55","author":"Barakat","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00004347-199407000-00009","article-title":"Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen","volume":"13","author":"Silva","year":"1994","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/07357909809115779","article-title":"Recent advances in understanding the molecular mechanisms of tamoxifen action","volume":"16","author":"Friedman","year":"1998","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/gyno.1999.5519","article-title":"Tamoxifen and endometrial pathologies: a prospective study","volume":"75","author":"Seoud","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bjc.6600157","article-title":"Tamoxifen induction of angiogenic factor expression in endometrium","volume":"86","author":"Hague","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/j.1600-0412.2000.079007604.x","article-title":"The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients","volume":"79","author":"Kavak","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/gyno.1998.5316","article-title":"Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen","volume":"73","author":"Mourits","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1097-0339(199812)19:6<417::AID-DC3>3.0.CO;2-P","article-title":"Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients","volume":"19","author":"Gill","year":"1998","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB37","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.5858\/2001-125-1047-TSBCDA","article-title":"The small blue cell dilemma associated with tamoxifen therapy","volume":"125","author":"Yang","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5122(96)01043-2","article-title":"Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen","volume":"25","author":"Dijkhuizen","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/gyno.1996.4595","article-title":"Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens","volume":"65","author":"Cohen","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/gyno.1994.1029","article-title":"Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients","volume":"52","author":"Cohen","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1993.1118","article-title":"Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas","volume":"49","author":"Altaras","year":"1993","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/gyno.1998.4941","article-title":"Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors","volume":"69","author":"Zelmanowicz","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3181\/00379727-203-43602","article-title":"Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens","volume":"203","author":"Branham","year":"1993","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1210\/en.133.1.419","article-title":"The antiestrogen tamoxifen induces c-fos and jun-B, but not c-jun or jun-D, protooncogenes in the rat uterus","volume":"133","author":"Nephew","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB45","first-page":"1360","article-title":"Induction of covalent DNA adducts in rodents by tamoxifen","volume":"52","author":"Han","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB46","first-page":"1475","article-title":"Lack of genotoxicity of tamoxifen in human endometrium","volume":"56","author":"Carmichael","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB47","first-page":"1045","article-title":"Endometrial carcinoma in breast cancer patients treated with tamoxifen: activation of K-ras protooncogene","volume":"4","author":"Varras","year":"1997","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB48","first-page":"812","article-title":"Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse","volume":"48","author":"Gottardis","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0960-9776(95)90156-6","article-title":"Tamoxifen does not promote tumour progression in surgically treated endometrial cancer","volume":"4","author":"Kaufmann","year":"1995","journal-title":"Breast"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7863\/jum.1993.12.5.275","article-title":"Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen","volume":"12","author":"Cohen","year":"1993","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB51","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2000.18.20.3459","article-title":"Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy","volume":"18","author":"Barakat","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB52","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","article-title":"Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound","volume":"18","author":"Gerber","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB53","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9378(98)70315-1","article-title":"Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy","volume":"178","author":"McGonigle","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiology.200.1.8657895","article-title":"MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation","volume":"200","author":"Ascher","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB55","first-page":"86","article-title":"The effects of tamoxifen therapy on the endometrium","volume":"21","author":"Zarbo","year":"2000","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB56","first-page":"580","article-title":"Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen","volume":"19","author":"Ozsener","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB57","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2000.18.20.3457","article-title":"Gynecologic surveillance of women on tamoxifen: first do no harm","volume":"18","author":"Runowicz","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB58","first-page":"466","article-title":"Reproductive tract pathology in asymptomatic women treated with tamoxifen","volume":"22","author":"Yuce","year":"2001","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB59","first-page":"35","article-title":"Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers","volume":"2","author":"Gibson","year":"1996","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(05)78216-7","article-title":"Should tamoxifen users be screened for endometrial lesions?","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB61","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1200\/JCO.1999.17.7.1967","article-title":"Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer","volume":"17","author":"Barakat","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9378(94)70209-8","article-title":"Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen","volume":"170","author":"Goldstein","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB63","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/1097-0142(20000815)89:4<800::AID-CNCR12>3.0.CO;2-Y","article-title":"Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study","volume":"89","author":"Althuis","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB64","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0140-6736(01)06150-5","article-title":"Screening recommendation for women taking tamoxifen","volume":"358","author":"Kawabata","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0028-2243(94)90166-X","article-title":"Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma","volume":"56","author":"Logmans","year":"1994","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(05)71567-1","article-title":"Tamoxifen and risk of endometrial cancer","volume":"357","author":"Marsh","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)71565-8","article-title":"Tamoxifen and risk of endometrial cancer","volume":"357","author":"Dickson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB68","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB69","doi-asserted-by":"crossref","unstructured":"Goldhirsch A., Wood WC, Gelber RD, Coates AS, Th\u00fcrlimann B, Senn H-J. Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer. J Clin Oncol 2003; 21 (in press) \u2013 published online July 7, 2003, 10.1200\/JCO.2003.04.576 (tentatively scheduled for the 9\/1\/2003 print issue)","DOI":"10.1200\/JCO.2003.04.576"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB70","first-page":"372","article-title":"Effets paradoxaux du Tamoxif\u00e8ne pour l'ut\u00e9rus de la femme. A propos de sept cas de myomes apparus sous traitement anti oestrogenique","volume":"18","author":"Boudouris","year":"1989","journal-title":"J. Gynecol. Obstet. Biol. Reprod. (Paris)"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB71","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1994.116","article-title":"Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth","volume":"69","author":"Cohen","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB72","doi-asserted-by":"crossref","unstructured":"Tamoxifen and the uterus and endometrium. Lancet 1989; 1: 375\u20136","DOI":"10.1016\/S0140-6736(89)91741-8"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB73","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0002-9378(88)90233-5","article-title":"Endometriosis developing during tamoxifen therapy","volume":"158","author":"Ford","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/gyno.1995.1188","article-title":"Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?","volume":"58","author":"Cohen","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB75","first-page":"867","article-title":"Cytopathologic features of small cells (SCT) seen in Pap smears after tamoxifen treatment","volume":"44","author":"Nahal","year":"1999","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB76","first-page":"1026","article-title":"Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen","volume":"48","author":"Ravdin","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/bjc.1989.235","article-title":"A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer","volume":"60","author":"Powles","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctrv.2003.09.004_BIB78","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jnci\/87.18.1359","article-title":"Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers","volume":"87","author":"Cook","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctrv.2003.09.004_BIB79","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N. Engl. J. Med."}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573720300183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030573720300183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T06:21:20Z","timestamp":1623565280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030573720300183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S030573720300183X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2003.09.004","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}